Enrichment of nuclear S100A4 during G2/M in colorectal cancer cells: possible association with cyclin B1 and centrosomes.

Clin Exp Metastasis

Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0310, Oslo, Norway.

Published: December 2015

S100A4 promotes metastasis in several types of cancer, but the involved molecular mechanisms are still incompletely described. The protein is associated with a wide variety of biological functions and it locates to different subcellular compartments, including nuclei, cytoplasm and extracellular space. Nuclear expression of S100A4 has been associated with more advanced disease stage as well as poor outcome in colorectal cancer (CRC). The present study was initiated to investigate the nuclear function of S100A4 and thereby unravel potential biological mechanisms linking nuclear expression to a more aggressive phenotype. CRC cell lines show heterogeneity in nuclear S100A4 expression and preliminary experiments revealed cells in G2/M to have increased nuclear accumulation compared to G1 and S cells, respectively. Synchronization experiments validated nuclear S100A4 expression to be most prominent in the G2/M phase, but manipulating nuclear levels of S100A4 using lentiviral modified cells failed to induce changes in cell cycle distribution and proliferation. Proximity ligation assay did, however, demonstrate proximity between S100A4 and cyclin B1 in vitro, while confocal microscopy showed S100A4 to localize to areas corresponding to centrosomes in mitotic cells prior to chromosome segregation. This might indicate a novel and uncharacterized function of the metastasis-associated protein in CRC cells.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10585-015-9742-1DOI Listing

Publication Analysis

Top Keywords

nuclear s100a4
12
s100a4
9
colorectal cancer
8
nuclear expression
8
s100a4 expression
8
nuclear
7
cells
6
enrichment nuclear
4
s100a4 g2/m
4
g2/m colorectal
4

Similar Publications

To investigate the functional role of S100A4 in advanced colorectal carcinoma (Ad-CRC) and locally advanced rectal carcinoma (LAd-RC) receiving neoadjuvant chemoradiotherapy (NCRT). We analyzed histopathological and immunohistochemical sections from 150 patients with Ad-CRC and 177 LAd-RC patients treated with NCRT. S100A4 knockout (KO) HCT116 cells were also used.

View Article and Find Full Text PDF

Dietary methionine supplementation promotes mice hematopoiesis after irradiation.

Mil Med Res

December 2024

Department of Blood Transfusion, Laboratory Medicine Center, the Second Affiliated Hospital, Army Medical University, Chongqing, 400037, China.

Background: With the increasing risk of nuclear exposure, more attention has been paid to the prevention and treatment of acute radiation syndrome (ARS). Although amino acids are key nutrients involved in hematopoietic regulation, the impacts of amino acids on bone marrow hematopoiesis following irradiation and the associated mechanisms have not been fully elucidated. Hence, it is of paramount importance to study the changes in amino acid metabolism after irradiation and their effects on hematopoiesis as well as the related mechanisms.

View Article and Find Full Text PDF
Article Synopsis
  • - Resistance to KRAS therapy in pancreatic cancer is linked to a process called epithelial-to-mesenchymal transition (EMT), which complicates effective treatment strategies.
  • - Chronic pancreatitis raises TGFβ levels in the tumor environment, promoting EMT and KRAS therapy resistance through a protein complex involving SMAD3, SMAD4, and NFAT5.
  • - Targeting NFAT5 could potentially overcome this resistance by disrupting the signaling pathways involved, presenting a new strategy for improving treatment outcomes in pancreatic cancer.
View Article and Find Full Text PDF

The dual role of FSP1 in programmed cell death: resisting ferroptosis in the cell membrane and promoting necroptosis in the nucleus of THP-1 cells.

Mol Med

July 2024

Department of Physiology, Clinical Anatomy and Reproductive Medicine Application Institute, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.

Article Synopsis
  • Acute monocytic leukemia-M5 (AML-M5) is difficult to treat, with high morbidity and a poor prognosis, highlighting the importance of programmed cell death (PCD) in its treatment.
  • The study investigates the effects of treating THP-1 cells with Erastin and IMP-366, discovering that inhibiting myristoylation leads to increased ferroptosis and necroptosis, characterized by specific cellular changes like lipid peroxidation and mitochondrial swelling.
  • Findings indicate that targeting FSP1 can switch the cell death pathways in AML-M5, suggesting new therapeutic strategies could be developed to combat this aggressive form of leukemia.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!